Posted by Michael Wonder on 22 Jan 2023
Pharmaceuticals campaigner moving to Australia after drug she desperately needs for spinal muscular atrophy is only funded for under 18s
22 January 2023 - This week, PHARMAC announced it was looking to fund a second drug to treat the neurological disease spinal muscular atrophy.
It's something pharmaceuticals campaigner Fiona Tolich had fought hard for, but she has a problem. PHARMAC is only looking to fund the medicines for children, so one of New Zealand's most vocal campaigners for better access to medicines has been forced to leave the country.
